Clinical Trials Browser

Phase 3 × Lung Neoplasms × vandetanib × Clear all

NCT00418886 2024-12-31

ZEAL

Phase 3 Completed

698 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00312377 2016-09-30

ZODIAC

Phase 3 Completed

1,690 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms